Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2113979 | Cancer Letters | 2010 | 9 Pages |
Abstract
Application of camptothecin (CPT) is hampered due to its extreme water insolubility and unpredictable side effects. Therefore, it is essential to establish an efficient and safe protocol for the administration of camptothecin against tumor growth and metastasis. Here, we encapsulated camptothecin with N-trimethyl chitosan (CPT–TMC) and tested it on BALB/c mice subcutaneously injected with murine hepatocellular carcinoma cells at the hindlimb feet pad. CPT–TMC effectively inhibited tumor growth and lymphatic metastasis, prolonged survival time, yet without apparent toxic effects. Thus, CPT–TMC may provide a novel and effective therapeutic strategy against human advanced hepatic cancer without conspicuous systemic toxic effects.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Lina Zhou, Xingyi Li, Xiancheng Chen, Zhiyong Li, Xianping Liu, Shengtao Zhou, Qian Zhong, Tao Yi, Yuquan Wei, Xia Zhao, Zhiyong Qian,